Business
Novo Nordisk Raises Outlook as Wegovy Pill Sales Hit $810 Million
Novo Nordisk raised its 2026 outlook for a third time after third-quarter sales of its Wegovy weight-loss pill beat forecasts,…
Novo Nordisk raised its 2026 outlook for a third time after third-quarter sales of its Wegovy weight-loss pill beat forecasts,…
Greenland's parliament has voted 16-0 to approve a security deal with the United States and Denmark, opening the way for…